Research Article

Additional Treatment with Low-Molecular-Weight Heparin Provides a Better Patient Outcome for Neonatal Pulmonary Hemorrhage with Unfractionated Heparin Treatment

Table 3

The changes of coagulation parameters function of each patient in the observation and control group before and after unfractionated heparin treatment with or without additional low-molecular-weight heparin treatment.

GroupTimeAPTT (s)PT (s)TT (s)FIB (g/L)

Control group ()Before treatment
After treatment
10.1766.1755.7463.963
0.0010.0010.0040.024
Observation group ()Before treatment
After treatment
21.0848.1736.7124.183
0.0010.0010.0010.016

The symbol of indicates compared with the control group; APTT: activated partial thromboplastin time; PT: prothrombin time; TT: thrombin time; FIB: fibrinogen.